Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Ceribell raised $35 million for its rapid-response EEG headband that quickly diagnoses patients suspected of having seizures with no visual symptoms.
The trade war between the U.S. and China has grown, with tariffs now reaching over $4.75 billion in U.S. medical device exports to the country.
Researchers from Cincinnati Children’s have grown esophageal organoids entirely from stem cells. Their work could yield treatments for GI diseases.
Luciole Medical raised about $5.5 million to commercialize its minimally invasive probe for measuring blood oxygen levels in the brain.
Roche and Foundation Medicine launched a blood test, analyzing 70 genes known to drive solid tumor growth, to guide precision cancer treatments.
MeMed raised $70 million for its immune system diagnostic for distinguishing between bacterial and viral infections, to reduce antibiotic misuse.
uBiome, which sells sequencing-based microbiome tests, is moving into therapeutics with $83 million in new funding, a new site and a new board member.
Medtronic moved to acquire spine surgery-focused Mazor Robotics, to merge it with its own implants, navigation and imaging offerings.
Boston Scientific launched a new kidney stone retrieval device allowing a single urologist to operate both a ureteroscope and basket simultaneously.
Fitbit launched a new health platform for insurance plans, employers and health systems, combining coaching and personalized digital interventions.